Women's Health
-
Moms’ and babies’ medical data predicts prematurity complications, Stanford Medicine-led study shows
Stanford Medicine scientists and their colleagues have shown they can tap mothers’ and babies’ medical records to better predict newborn health risks.
-
Predicting preeclampsia from urine, blood
Biological molecules in urine and gene-activity signals in blood can predict early in pregnancy which women develop preeclampsia, Stanford Medicine researchers found.
-
Infants do better with buprenorphine
Stanford Medicine and Harvard researchers found that buprenorphine for opioid use disorder treatment during pregnancy was linked to better outcomes for newborns than methadone.
-
LeRoy Heinrichs dies at 90
The Stanford Medicine professor emeritus of obstetrics and gynecology was an early adopter of less invasive surgical techniques, a pioneer in treating infertility and an evangelist for virtual medical training.
-
Expert committee on reproductive health
A new Stanford Medicine committee is addressing medical, equity, safety, legal and other concerns arising from the Supreme Court ruling on abortion.
-
Epilepsy linked to mood symptoms in pregnancy
Stanford-led study gives new insight into how epilepsy, pregnancy and symptoms of mood disorders interact.
-
Cancer tolerated by immune system
Cancer cells in the lymph nodes trick the immune system into tolerating their presence and welcoming metastasis, a pair of Stanford studies find. Blocking this process could stop cancer’s spread.
-
Reshuffling liver transplant waitlist
An updated scoring system developed by Stanford Medicine researchers will more accurately prioritize patients on the liver transplant waiting list based on medical urgency.
-
Moms of sick kids seek more health care
Mothers facing the daily challenges of caring for children with congenital anomalies seek more health care and mental health services than other mothers, a Stanford-led study finds.
-
Two-mom families face more pregnancy risks
In the first U.S. population-based study of obstetric health among sexual- and gender-minority parents, Stanford researchers find higher rates of some birth complications.
-
New chair of anesthesiology
Bateman, a Harvard faculty member and prominent health care leader, brings his expertise as a researcher in maternal health and faculty development to Stanford.
-
Breast cancer mutations don’t lower survival rates
Newly diagnosed breast or ovarian cancer patients who carry common cancer-associated mutations have similar or better short-term survival rates than those with no mutations, researchers report.
-
Robot aids cancer surgery
Stanford Health Care – ValleyCare physician performs surgery on a cancer patient with the help of a da Vinci robotic system. The technology eases patients’ recovery and offers surgeons a clear view of the procedure.
-
Blood biomarkers predict labor onset
About three weeks before delivery, a pregnant woman’s body shifts into a pre-labor phase characterized by changes in immune, hormonal and blood-clotting signals.
-
High nitrate levels in water linked to preterm birth
Women exposed to higher levels of nitrate in drinking water were more likely to deliver very early, according to a study of 1.4 million California births.
-
Fewer C-sections for California moms
A statewide quality improvement project has reduced cesarean section rates for low-risk, first-time mothers, while also improving outcomes for babies.
-
Epidurals not linked to autism risk
Refuting an earlier study, researchers found that epidural anesthesia, commonly administered for pain relief during labor, does not increase the risk for autism in children.
-
SHC – ValleyCare rakes in honors
Stanford Health Care – ValleyCare was recognized for overall quality, safety and performance in a number of specialties.
-
Investigating preeclampsia, heart disease
Stanford researchers will study the connections between preeclampsia in pregnant women and the subsequent risk of atherosclerosis as the women grow older.
-
IUD device aids contraception in India
Stanford researchers and their colleagues have tested a new contraceptive device that they say could provide broader access to long-acting contraception in developing countries.
- Aging & Geriatrics
- AI, Technology & Innovation
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Biochemistry
- Bioengineering
- Blood Disorders (Hematology)
- Cancer
- Cardiology
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Dermatology
- Diabetes
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Endocrinology
- Environment & Sustainability
- Epidemiology & Population Health
- Ethics
- Genetics
- Global Health
- Health Policy
- Immunology
- Infectious Disease
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Microbiology
- Neurobiology
- Neurology & Neurosurgery
- Nutrition
- Obituaries
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedics
- Palliative Care
- Pathology
- Pediatrics
- Physiology
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Radiology
- Stanford Medicine
- Stem Cells
- Surgery
- Transplantation
- Urology
- Vaccines
- Wellness
- Women's Health